JUN 2, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Arsenic Trioxide (Labeling)
U.S. Food and Drug Administration
This is an FDA supplemental approval action for labeling of arsenic trioxide; it documents a regulatory decision, not clinical trial evidence or efficacy data.
Reported
Approval date2026-06-02
Application numberANDA206228
Submission typeSupplement (Labeling)